From: Pleiotropic effects of fenofibrate therapy on rats with hypertriglycemia
Variables | CONT | UT | LFF | HFF |
---|---|---|---|---|
TG (mmol/L) | 0.95 ± 0.06* | 2.30 ± 0.40 | 2.18 ± 0.35 | 1.96 ± 0.24# |
TC (mmol/L) | 3.27 ± 0.25 | 3.31 ± 0.36 | 3.30 ± 0.24 | 3.28 ± 0.16 |
LDL-C (mmol/L) | 1.99 ± 0.13 | 2.04 ± 0.16 | 2.01 ± 0.24 | 2.00 ± 0.21 |
HDL-C (mmol/L) | 1.06 ± 0.04 | 0.90 ± 0.04 | 0.97 ± 0.05 | 1.03 ± 0.03# |
ApoA1 (mmol/L) | 1.03 ± 0.03 | 0.86 ± 0.04 | 0.92 ± 0.02 | 0.99 ± 0.05# |
ApoB (mmol/L) | 0.96 ± 0.05 | 0.98 ± 0.03 | 0.98 ± 0.04 | 0.98 ± 0.02 |
ALT (U/L) | 27.5 ± 2.9 | 30.2 ± 1.6 | 29.0 ± 2.2 | 28.2 ± 1.5 |
AST (U/L) | 28.4 ± 2.3 | 31.0 ± 2.5 | 29.5 ± 2.4 | 28.6 ± 1.0 |
FBG (mmol/L) | 5.88 ± 0.15 | 6.04 ± 0.14 | 6.00 ± 0.13 | 6.00 ± 0.10 |
CRP (mg/L) | 1.80 ± 0.13* | 9.20 ± 1.04 | 9.09 ± 0.98 | 8.92 ± 0.76# |
MDA(nmol/L) | 0.98 ± 0.11* | 3.35 ± 0.13 | 3.21 ± 0.16 | 3.03 ± 0.12# |
NO(μmol/L) | 13.21 ± 1.03* | 9.16 ± 1.12 | 9.35 ± 1.08 | 9.98 ± 1.00# |
ADMA (nmol/L) | 68.24 ± 9.13* | 97.33 ± 10.72 | 95.46 ± 10.33 | 91.25 ± 11.25# |